Noticias Ypsomed España

Burgdorf - Společnost Ypsomed spolupracuje se společností CamDiab Ltd., která je vývojářem aplikace CamAPS FX pro řízení hladiny glukózy prostřednictvím inzulínových pump s využitím adaptivního hybridního přístupu s uzavřenou smyčkou. V první polovině roku 2022 bude toto snadno použitelné řešení smyčky uvedeno na trh pro systém mylife YpsoPump, a to nejprve ve vybraných významných zemích Evropy a v průběhu roku budou následovat další teritoria. Pacienti pak mohou připojit systém mylife YpsoPump k mobilní aplikaci mylife CamAPS FX pro Android a je jim umožněna podpora podávání inzulínu na základě algoritmů včetně bolusu z osobního chytrého telefonu.

Ypsomed partners with CamDiab Ltd to drive on smartphone based adaptive automated insulin delivery (AID)

Press Releases Ypsomed Group

Burgdorf – Ypsomed partners with CamDiab Ltd, the developer of CamAPS FX, an app to manage glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach. During the first half of 2022, this easy-to-use loop solution will be launched for the mylife YpsoPump system, starting in selected major countries in Europe and followed by other territories in the course of the year. Patients can then connect the mylife YpsoPump system to the mylife CamAPS FX Android mobile application and are enabled to algorithm-based insulin delivery support including bolus from the personal smartphone.

Sébastien Delarive to become new Senior Vice President Diabetes Care
Sébastien Delarive to become new Senior Vice President Diabetes Care.

Press Releases Ypsomed Group

Burgdorf – With the aim of focusing on changing customer needs, Ypsomed is stepwise optimizing the organisation of the business units and the Management Board.

World’s first autoinjector with fully integrated connectivity

Press Releases Ypsomed Group

Burgdorf – Ypsomed has introduced the world’s first autoinjector for prefilled syringes with integrated connectivity. The YpsoMate On combines the advantages of the proven YpsoMate autoinjector with the options of digital therapy support. The YpsoMate On follows an eco-design principle which allows easy recycling of electronic components and encourages the use of sustainable components.

Press Releases Ypsomed Group

Burgdorf – Ypsomed has expanded the range of features of the mylife YpsoPump insulin pump system. New - the app-based integration of the Dexcom G6 Continuous Glucose Monitoring (CGM) System enables people with diabetes to continuously manage their therapy via their smartphone. Users of the mylife YpsoPump receive the advanced function of the pump system – called “mylife Assist” – via an update to the mylife App. The first countries launching mylife Assist are Germany, Switzerland, Austria and Denmark, with further countries following soon.